Tumor dormancy and relapse:understanding the molecular mechanisms of cancer recurrence

Your Location：

Home >

Browse articles >

Tumor dormancy and relapse:understanding the molecular mechanisms of cancer recurrence

REVIEW | Updated：2025-12-13

- Tumor dormancy and relapse:understanding the molecular mechanisms of cancer recurrence
- “In the battle against cancer, understanding tumor dormancy is crucial. This review delves into the cellular, angiogenic, and immunological aspects of dormancy, shedding light on current therapeutic strategies targeting dormant cells, including combination therapies and immunotherapies, which could prevent cancer recurrence and improve patient outcomes.”
- Muhammad Tufail , Can-Hua Jiang , Ning Li
- Military Medical Research Vol. 12, Issue 9, Pages: 1456-1491(2025)
- Affiliations：
  1.Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha 410008, China
  2.Institute of Oral Precancerous Lesions, Central South University, Changsha 410008, China
  3.Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital, Central South University, Changsha 410008, China
  4.National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China
- Author bio：
  * Ning Li liningoms@csu.edu.cn
- Funds：
- DOI： 10.1186/s40779-025-00595-2
  CLC：
- Accepted：26 January 2025 ，
- Accepted：
Scan QR Code
DOI：
DOI：

AI Introduction
Full Text(HTML)
Figs( 3 ) Tabs( 0 )
References
Publication Info
Metrics

71

Views

51

Downloads

0

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Related Articles

Pathophysiology-guided biomarkers and therapeutics for precision trauma medicine in polytrauma with musculoskeletal injuries

Sepsis in burns: lessons learned, challenges remain

Exosomal mediators in sepsis and inflammatory organ injury: unraveling the role of exosomes in intercellular crosstalk and organ dysfunction

Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients

From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Related Author

Ning Li

Peethambaran Arun

Chetan Y. Pundkar

Manoj Y. Govindarajulu

Rex Jeya Rajkumar Samdavid Thanapaul

David Greenhalgh

Folke Sjöberg

Moustafa Elmasry

Related Institution

The Geneva Foundation

Blast-Induced Neurotrauma Branch, Center for Military Psychiatry and Neuroscience, Walter Reed Army Institute of Research

Medical Laboratory Science Department, College of Health Sciences, University of Sharjah

Department of Burns, Shriners Children’s Northern California and Department of Surgery, University of California, Davis

Department of Biomedical and Clinical Sciences, Linköping University